PDB36 COST SAVINGS IN TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN A BASAL-BOLUS TREATMENT CONCEPT IN GERMANY
A Neilson, S Pscherer, FW Dippel, ES DietrichVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)75014-2
File:
PDF, 81 KB
english, 2009